What You Should Know:

您应该知道：

– Curavit Clinical Research, a leader in decentralized clinical trials (DCTs) for digital therapeutics (DTx), successfully completed a study for the Sana Device, a virtual reality (VR) mask aiming to reduce post-traumatic stress disorder (PTSD) symptoms.

–Curavit Clinical Research是数字治疗（DTx）分散临床试验（DCT）的领导者，成功完成了Sana设备的研究，Sana设备是一种虚拟现实（VR）面罩，旨在减少创伤后应激障碍（PTSD）症状。

– Overall, this study represents a significant step forward in the development of VR-based treatments for PTSD. If approved, the Sana Device could offer a valuable tool for patients struggling with this condition.

–总的来说，这项研究代表了基于VR的创伤后应激障碍治疗方法发展的重要一步。如果获得批准，Sana设备可以为患有这种疾病的患者提供有价值的工具。

Study Details

研究详细信息

More than 45 patients were recruited from a Veteran’s hospital to participate in the 28-day study. Curavit exceeded Sana’s expectations for participant retention with a 76% retention rate. Curavit CRCs captured participant experience with the Sana Device using industry-standard PHQ-9 survey and the Columbia Suicide Severity Risk Scale (C-SSRS) to capture levels of depression – all done remotely using electronic patient-reported outcomes assessments..

从一家退伍军人医院招募了45多名患者参加为期28天的研究。Curavit以76%的保留率超过了Sana对参与者保留率的期望。Curavit CRCs使用行业标准PHQ-9调查和哥伦比亚自杀严重程度风险量表（C-SSRS）捕捉参与者使用Sana设备的经验，以捕捉抑郁水平-所有这些都是通过电子患者报告的结果评估远程完成的。。

The Sana Device is a wearable device that aims to offer anxiety relief on-demand. The trial was carried out with a grant from CDMRP funds, disbursed through the Military Operational Medicine Research Program (part of the DoD). It was designed to gather evidence on the Device’s ability to allow patients suffering from PTSD to gain additional relief whilst on waiting lists for further specialty care..

Sana设备是一种可穿戴设备，旨在按需缓解焦虑。该试验是在CDMRP基金的资助下进行的，该基金通过军事行动医学研究计划（国防部的一部分）支付。它旨在收集有关该设备的能力的证据，以使患有创伤后应激障碍的患者在等待进一步专科护理的名单上获得额外的缓解。。

Potential Impact

潜在影响

– Improved access to care: The Sana Device could offer on-demand anxiety relief for PTSD sufferers, especially those waiting for specialized treatment.

–改善获得护理的机会：Sana设备可以为创伤后应激障碍患者，特别是那些等待专业治疗的患者提供按需焦虑缓解。

– Market access and affordability: Demonstrating healthcare economic value can lead to wider insurance coverage and reimbursement.

–市场准入和负担能力：证明医疗保健的经济价值可以扩大保险范围和报销。

– Paving the way for DTx: Curavit’s HEOR services help DTx companies gather real-world data to secure market access and impact patient lives.

–为DTx铺平道路：Curavit的HEOR服务帮助DTx公司收集真实世界的数据，以确保市场准入并影响患者生活。

“Sana Health’s origin story is emblematic of the company’s determination to bring innovative treatments to patients suffering from a range of disorders, and we are honored to help them along this journey,” concluded Joel Morse, CEO and co-founder of Curavit. “Our virtual site model with integrated HEOR data capture is key to helping companies like Sana reach both their scientific and commercial goals faster and give more patients alternative or complementary non-invasive treatment options.”.

Curavit首席执行官兼联合创始人乔尔·莫尔斯（JoelMorse）总结道：“萨那健康（SanaHealth）的起源故事象征着该公司决心为患有一系列疾病的患者提供创新治疗，我们很荣幸能在这一过程中为他们提供帮助。”。“我们的集成HEOR数据捕获的虚拟站点模型对于帮助萨那这样的公司更快地实现其科学和商业目标以及为更多患者提供替代或补充的非侵入性治疗选择至关重要。”。